Related Experiment Video
Updated: Jul 18, 2026

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
Published on: January 3, 2017
Nutraceuticals in Depression Management: Current Evidence and Perspectives
Parvinder Mann1, Geeta Jangra1, Komal Saini1
1Institute of Pharmaceutical Sciences, Kurukshetra University Kurukshetra-136119, Haryana, India.
Nutraceuticals like omega-3 fatty acids and Ashwagandha show antidepressant effects, offering a natural approach to managing depression symptoms. These compounds may help improve mood and cognitive function as complementary therapies.
Area of Science:
- Nutritional Psychiatry
- Pharmacology
- Neuroscience
Background:
- Depression is a common mood disorder with significant public health impact.
- Pharmacotherapy is a primary treatment but can have adverse effects.
- Nutraceuticals are emerging as a potential alternative or complementary approach.
Purpose of the Study:
- To review the efficacy of nutraceuticals in managing depression.
- To explore naturally derived compounds for therapeutic benefits in depression.
- To address limitations of traditional antidepressant therapies.
Main Methods:
- Comprehensive literature analysis of relevant research.
- Inclusion of studies on nutraceuticals' effects on depression symptoms.
- Review of patent perspectives and clinical studies.
Main Results:
- Several nutraceuticals, including omega-3 fatty acids, dietary fibers, Ashwagandha, and valerian, demonstrate antidepressant properties.
- These compounds show promise in improving depressive symptoms.
- Evidence suggests enhancement of neuroplasticity, neurogenesis, and neurotransmitter regulation.
Conclusions:
- Nutraceuticals present a novel strategy for alleviating depression symptoms.
- Increased intake of specific nutraceuticals may help delay depression onset and progression.
- Dietary fibers, omega-3 fatty acids, and phytochemicals can serve as complementary therapies.
More Related Videos
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
G-protein Coupled Receptors
Depression: Overview
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...